Resurgent Methamphetamine Use at Treatment Admission in the United States, 2008-2017
Resurgent Methamphetamine Use at Treatment Admission in the United States, 2008-2017
复制标题
DOI：
10.2105/ajph.2019.305527
复制
发表时间：
2020-04-01
影响因子：
12.7
通讯作者：
Mustaquim, Desiree
中科院分区：
文献类型：
--
作者：
Jones, Christopher M.;Olsen, Emily O.;Mustaquim, Desiree
目标.评估美国甲基苯丙胺使用的趋势和相关性。数据来自2008-2017年治疗事件数据集中12岁或以上人群中的15747334例药物相关治疗。我们分析趋势并使用多变量逻辑回归。与甲基苯丙胺相关的入院率从2008年的15.1%上升到2017年的23.6%。几乎所有人口群体都出现了增长。甲基苯丙胺注射从2008年的17.5%上升到2017年的28.4%。在与甲基苯丙胺有关的入院人数中，海洛因使用从2008年的5.3%增加到2017年的23.6%。与入院时报告使用甲基苯丙胺的几率增加相关的特征包括女性;年龄在35至44岁之间的入院;中西部、南部和西部的入院;失业;不在劳动力中;生活依赖;无家可归;以及有刑事司法、卫生保健提供者或其他社区治疗来源的转诊。在过去十年中，涉及使用甲基苯丙胺的治疗入院人数大幅增加，似乎与美国持续的类阿片危机有关。需要努力调动公共卫生预防、治疗和应对战略，以应对甲基苯丙胺使用和过量使用的上升。
Objectives. To evaluate trends and correlates of methamphetamine use in the United States.Methods. Data are from 15 747 334 drug-related treatment admissions among persons aged 12 years or older in the 2008-2017 Treatment Episode Data Set. We analyzed trends and used multivariable logistic regression.Results. Methamphetamine-related admissions increased from 15.1% of drug-related treatment admissions in 2008 to 23.6% in 2017. Increases occurred among nearly all demographic groups. Methamphetamine injection increased from 17.5% of admissions in 2008 to 28.4% in 2017. Among methamphetamine-related admissions, heroin use increased from 5.3% of admissions in 2008 to 23.6% in 2017. Characteristics associated with increased odds of reporting methamphetamine use at admission included female sex; admissions aged 35 to 44 years; admissions in the Midwest, South, and West; unemployment; not in labor force; living dependent; living homeless; and having a referral from criminal justice, a health care provider, or other community treatment source.Conclusions. Treatment admissions involving methamphetamine use increased significantly over the past decade and appear to be linked to the ongoing opioid crisis in the United States. Efforts to mobilize public health prevention, treatment, and response strategies to address rising methamphetamine use and overdose are needed.